Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and growth factors regulate the aggressiveness and proliferative activity of keratocystic odontogenic tumors.
暂无分享,去创建一个
R. Jaeger | A. L. Ribeiro | J. J. Pinheiro | M. Kataoka | S. Alves-Júnior | R. M. Nobre | R. F. F. Barroso
[1] T. Kaczmarzyk,et al. A systematic review of the recurrence rate for keratocystic odontogenic tumour in relation to treatment modalities. , 2012, International journal of oral and maxillofacial surgery.
[2] F. Mannello,et al. Nuclear localization of matrix metalloproteinases. , 2012, Progress in histochemistry and cytochemistry.
[3] R. Jaeger,et al. Invadopodia proteins, cortactin and membrane type I matrix metalloproteinase (MT1‐MMP) are expressed in ameloblastoma , 2011, Histopathology.
[4] R. de Almeida Freitas,et al. Immunohistochemical expression of matrix metalloproteinases 1, 2, 7, 9, and 26 in the calcifying cystic odontogenic tumor. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[5] H. Galvão,et al. Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[6] H. Galvão,et al. Immunohistochemical expression of nuclear factor κB, matrix metalloproteinase 9, and endoglin (CD105) in odontogenic keratocysts, dentigerous cysts, and radicular cysts. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[7] H. Zartab,et al. Immunohistochemical Comparison of the Expression of p53 and MDM2 Proteins in Ameloblastomas and Keratocystic Odontogenic Tumors , 2011, The Journal of craniofacial surgery.
[8] Sérgio de Melo Alves Júnior,et al. Expression of metallothionein in ameloblastoma. A regulatory molecule? , 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[9] Hyung Gyun Kim,et al. Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling. , 2011, Molecular nutrition & food research.
[10] J. Carvalho,et al. A comparative immunohistochemical analysis of COX-2, p53, and Ki-67 expression in keratocystic odontogenic tumors. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[11] Ingebrigt Sylte,et al. Regulation of matrix metalloproteinase activity in health and disease , 2011, The FEBS journal.
[12] P. Boffano,et al. Keratocystic odontogenic tumor (odontogenic keratocyst): preliminary retrospective review of epidemiologic, clinical, and radiologic features of 261 lesions from University of Turin. , 2010, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[13] R. Leonardi,et al. MMP-13 expression in keratocyst odontogenic tumour associated with NBCCS and sporadic keratocysts. , 2010, Oral diseases.
[14] P. Lequerica-Fernández,et al. Immunohistochemical comparative study of the odontogenic keratocysts and other odontogenic lesions. , 2010, Medicina oral, patologia oral y cirugia bucal.
[15] R. Jaeger,et al. Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour , 2010, Histopathology.
[16] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[17] I. van der Waal,et al. Characterization and management of the keratocystic odontogenic tumor in relation to its histopathological and biological features. , 2010, Oral oncology.
[18] J. Bodart. Extracellular‐regulated kinase—mitogen‐activated protein kinase cascade: Unsolved issues , 2010, Journal of cellular biochemistry.
[19] Brenda L. Nelson,et al. Keratocystic Odontogenic Tumor , 2010, Head and neck pathology.
[20] L. Campbell,et al. Activated extracellular signal‐regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma , 2009, Cancer.
[21] R. Buccione,et al. Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix , 2009, Cancer and Metastasis Reviews.
[22] Mohammad A. Ali. Expression of extracellular matrix metalloproteinase inducer in odontogenic cysts. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[23] K. Pereira,et al. Immunohistochemical expression of MMPs 1, 7, and 26 in syndrome and nonsyndrome odontogenic keratocysts. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[24] Alex Y Strongin,et al. Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer. , 2008, Cancer research.
[25] D. Radisky,et al. Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development , 2008, Clinical & Experimental Metastasis.
[26] W. Parks,et al. Activation and silencing of matrix metalloproteinases. , 2008, Seminars in cell & developmental biology.
[27] A. Noël,et al. Matrix metalloproteinases at cancer tumor-host interface. , 2008, Seminars in cell & developmental biology.
[28] A. Ulhuq. Cysts of the oral and maxillofacial regions , 2008, BDJ.
[29] G. Ligresti,et al. Extracellular Matrix: A Matter of Life and Death , 2008, Connective tissue research.
[30] R. Herbst,et al. Expression of epidermal growth factor (EGF)/transforming growth factor-α by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice , 2007, Molecular Cancer Therapeutics.
[31] S. Shukla,et al. Clinical significance of MMP‐2 and MMP‐9 in patients with oral cancer , 2007, Head & neck.
[32] H. Galvão,et al. Participação das metaloproteinases da matriz na etiopatogenia dos cistos odontogênicos , 2007 .
[33] O. Rath,et al. MAP kinase signalling pathways in cancer , 2007, Oncogene.
[34] M. Ozsahin,et al. The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications , 2006, Radiation oncology.
[35] J. Delaissé,et al. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. , 2004, Bone.
[36] A. S. Moretti,et al. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity , 2004, Histopathology.
[37] Y. Itoh,et al. Matrix metalloproteinases in cancer. , 2002, Essays in biochemistry.
[38] M. Shear. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 3. Immunocytochemistry of cytokeratin and other epithelial cell markers. , 2002, Oral oncology.
[39] M. Shear. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2. Proliferation and genetic studies. , 2002, Oral oncology.
[40] M. Shear,et al. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour. , 2002, Oral oncology.
[41] L. Sobin,et al. World Health Organization classification of tumors , 2000, Cancer.
[42] Y. Takenoshita,et al. Interleukin-1α-dependent Regulation of Matrix Metalloproteinase-9 (MMP-9) Secretion and Activation in the Epithelial Cells of Odontogenic Jaw Cysts , 2000, Journal of dental research.
[43] A. Piattelli,et al. Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. , 1998, Oral oncology.
[44] S. Cohen,et al. Epidermal growth factor , 1972, The Journal of investigative dermatology.
[45] P. Toller,et al. Origin and growth of cysts of the jaws. , 1967, Annals of the Royal College of Surgeons of England.
[46] V. Olgac,et al. Expressions of bax, bcl-2 and Ki-67 in odontogenic keratocysts (Keratocystic Odontogenic Tumor) in comparison with ameloblastomas and radicular cysts. , 2012, Turk patoloji dergisi.
[47] I. Căruntu,et al. Matrix metalloproteinases involvement in pathologic conditions. , 2010, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[48] I. van der Waal,et al. Biological pathways involved in the aggressive behavior of the keratocystic odontogenic tumor and possible implications for molecular oriented treatment - an overview. , 2010, Oral oncology.
[49] B. Fingleton. Matrix metalloproteinases: roles in cancer and metastasis. , 2006, Frontiers in bioscience : a journal and virtual library.
[50] H. Philipsen. Keratocystic odontogenic tumour , 2005 .
[51] Tang Hai-kuo. Establishment and biological behavior of human ameloblastoma xenograft in nude mice , 2004 .
[52] Cdm Fletcher,et al. World Health Organization Classification of Tumours , 2002 .
[53] H. Birkedal‐Hansen,et al. Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.